A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
一项针对卡介苗(BCG)无反应的非肌层浸润性膀胱癌患者的杜伐利尤单抗联合BCG或体外放射治疗的I期临床试验:印第安纳州癌症研究网络GU16-243 ADAPT-BLADDER研究
期刊:
影响因子:
doi:10.1016/j.eururo.2023.01.017
Hahn, Noah M; O'Donnell, Michael A; Efstathiou, Jason A; Zahurak, Marianna; Rosner, Gary L; Smith, Jeff; Kates, Max R; Bivalacqua, Trinity J; Tran, Phuoc T; Song, Daniel Y; Baras, Alex S; Matoso, Andres; Choi, Woonyoung; Smith, Kellie N; Pardoll, Drew M; Marchionni, Luigi; McGuire, Bridget; Grace Phelan, Mary; Johnson, Burles A 3rd; O'Neal, Tanya; McConkey, David J; Rose, Tracy L; Bjurlin, Marc; Lim, Emerson A; Drake, Charles G; McKiernan, James M; Deutsch, Israel; Anderson, Christopher B; Lamm, Donald L; Geynisman, Daniel M; Plimack, Elizabeth R; Hallman, Mark A; Horwitz, Eric M; Al-Saleem, Essel; Chen, David Y T; Greenberg, Richard E; Kutikov, Alexander; Guo, Gordon; Masterson, Timothy A; Adra, Nabil; Kaimakliotis, Hristos Z